{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:26Z","timestamp":1791118766131,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T00:00:00Z","timestamp":1378684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073737","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T18:29:15Z","timestamp":1378751355000},"page":"e73737","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes"],"prefix":"10.1371","volume":"8","author":[{"given":"Basile","family":"Gravez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tarjus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Jimenez-Canino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"El Moghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smail","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Alvarez","family":"de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"J Cosin","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.HYP.34.1.138","article-title":"Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats","volume":"34","author":"A Fortuno","year":"1999","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/16.suppl_1.14","article-title":"Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth","volume":"16","author":"P Muniz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0952-3278(92)90227-A","article-title":"A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery","volume":"45","author":"T Uchida","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide","volume":"205","author":"T Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"N Farman","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"S Messaoudi","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"B Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"B Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"F Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure","volume":"53","author":"B Lopez","year":"2009","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"B Lopez","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"B Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"14299","DOI":"10.1074\/jbc.M005363200","article-title":"Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene","volume":"276","author":"XM Ou","year":"2001","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1210\/en.2012-1210","article-title":"Identification of permissive insertion sites for generating functional fluorescent mineralocorticoid receptors","volume":"153","author":"C Aguilar-Sanchez","year":"2012","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/en.2006-1438","article-title":"Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?","volume":"148","author":"G Fejes-Toth","year":"2007","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/nar\/19.7.1563","article-title":"Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter","volume":"19","author":"F Gouilleux","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"F180","DOI":"10.1152\/ajprenal.00301.2002","article-title":"Conditional gene expression in renal collecting duct epithelial cells: use of the inducible Cre-lox system","volume":"286","author":"A Ouvrard-Pascaud","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1073\/pnas.95.6.2973","article-title":"Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists","volume":"95","author":"G Fejes-Toth","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1210\/en.2010-0237","article-title":"Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart","volume":"151","author":"C Latouche","year":"2010","journal-title":"Endocrinology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cardfail.2012.02.005","article-title":"Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee","volume":"18","author":"J Butler","year":"2012","journal-title":"J Card Fail"},{"key":"ref23","first-page":"1703","article-title":"The 2012 ESC Guidelines on Heart Failure","volume":"33","author":"J Taylor","year":"2012","journal-title":"Eur Heart J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.RES.0000158287.49872.4e","article-title":"Multi-tasking RGS proteins in the heart: the next therapeutic target?","volume":"96","author":"EL Riddle","year":"2005","journal-title":"Circ Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor-1","volume":"3","author":"HR Lijnen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.biochem.78.082107.133320","article-title":"Conformational pathology of the serpins: themes, variations, and therapeutic strategies","volume":"78","author":"B Gooptu","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: possible role during stress and remodeling","volume":"64","author":"MW Schellings","year":"2004","journal-title":"Cardiovasc Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ng850","article-title":"Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition","volume":"30","author":"JR Mao","year":"2002","journal-title":"Nat Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00731326","article-title":"Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer","volume":"12","author":"A Mackiewicz","year":"1995","journal-title":"Glycoconj J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.atherosclerosis.2008.05.038","article-title":"Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study","volume":"202","author":"G Engstrom","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/endo.130.1.1309341","article-title":"Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter","volume":"130","author":"B Couette","year":"1992","journal-title":"Endocrinology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/jme.0.0310573","article-title":"Determinants of spironolactone binding specificity in the mineralocorticoid receptor","volume":"31","author":"FM Rogerson","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"AS Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/HYPERTENSIONAHA.109.140384","article-title":"Mineralocorticoid receptors in myocardial infarction","volume":"54","author":"CT Stier Jr","year":"2009","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mol.51.2.285","article-title":"Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone","volume":"51","author":"C Massaad","year":"1997","journal-title":"Mol Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro","volume":"63","author":"TL Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2004.09.009","article-title":"Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"44","author":"T Tsutamoto","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/cs1020381","article-title":"Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart","volume":"102","author":"M Satoh","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2460\/ajvr.68.10.1058","article-title":"Effects of oral administration of furosemide and torsemide in healthy dogs","volume":"68","author":"Y Hori","year":"2007","journal-title":"Am J Vet Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1253\/circj.67.384","article-title":"Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure","volume":"67","author":"M Yamato","year":"2003","journal-title":"Circ J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"M Uechi","year":"2003","journal-title":"J Vet Med Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jvc.2011.10.001","article-title":"Use of the loop diuretic torsemide in three dogs with advanced heart failure","volume":"13","author":"MA Oyama","year":"2011","journal-title":"J Vet Cardiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T16:01:52Z","timestamp":1563897712000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073737"}},"subtitle":[],"editor":[{"given":"Philippe","family":"Rouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,9]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073737","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,9]]}}}